1. Turkish Journal of Pathology (http://www.turkjpath.org)(ISSN:1018-5615 / E-ISSN:1309-5730) is the official journal of the Federation of Turkish Pathology Societies. The Journal is a peer-reviewed scientific journal published every four months, three times a year (January, May, September), and aims to reach all relevant national and international medical institutions and persons in electronic versions free of charge. Articles in English are welcomed.
2. The Journal is devoted to the continuing education of national and international practicing pathologists, and to provide a forum for social and scientific communication in the field. Studies that emphasize these aims provide the basis of publication, including original articles, case reports, reviews, abstracts from annual meetings, letters to the editor, book reviews, biographies and articles with social content. The Turkish Journal of Pathology accepts only invited review articles.
3. A submitted article must not have been previously published in print or electronic format and must not be under consideration for publication at another journal or electronic media, and, if accepted, must not be published elsewhere in any languages in a similar form. Articles presented at a meeting or symposium or in electronic form are accepted if this is stated.
The Turkish Journal of Pathology accepts advertising for products and services that are of interest to users professionally. The decision of acceptance is subject to consultation with the journal's editorial team. The editorial team reserves the right to accept and reject advertising proposals.
5. REVENUE SOURCES
The sources of income of the Turkish Journal of Pathology include institutional support (Federation of the Turkish Pathology Societies) and display advertising for pharmaceutical and nonpharmaceutical products.
6. AUTHORSHIP & CONTRIBUTORSHIP CRITERIA
Every author specified in the study should have properly
contributed to the article, should meet the authorship criteria and
should be responsible for the contributed content. Each section in
the article regarding study results and integrity should be the under
the responsibility of at least one author.
The Turkish Journal of Pathology accepts the criteria of the
International Committee of Medical Journal Editors (http://www.icmje.org). The author should accordingly;
1.Make a significant contribution to the planning and design or analysis or interpretation or both of the study,
2.Make a contribution to the writing or revision of scientific content of the article,
3.Approve the final version of the article that is going to be published,
4.Accept responsibility for the appropriate analysis and resolution of questions related to the integrity and accuracy of a section of
a study and for all aspects of the study.
For multicenter studies, all declared authors should meet the above
authorship criteria. Contribution such as searching for and finding
financial support for the study or only collecting data or general
help and guidance for those conducting the study do not confer
the right to authorship. Individuals who have contributed to the
study but do not meet authorship criteria can be included in the
"Acknowledgements" section after their consent is obtained. The author order should be the joint decision of all authors. The editor
can ask the individual contribution of each author and may find it
appropriate to publish this information to prevent an unnecessary
increase in the number of authors or unfair academic or similar
7. ETHICAL RESPONSIBILITY
Authors are responsible for their articles' conformity to ethical
rules. The study protocol for human experimentation must
conform the ethical guidelines established in the World Medical
Association Declaration of Helsinki (http://www.healthscience.net/resources/declaration-of-helsinki/). Therefore, all articles
submitted for publication must specify that the ethic standards of
the above committee were adhered to. Any necessary permission
documents from local and international ethic committees must
also be sent with the article. Authors must specify in the method(s)
section that they performed the study according to these principles
and that they obtained "informed consent" from their institution's
ethic committees and the participants.
Articles reporting the results of experimental studies on animals
must include a statement that study protocol was approved by the
animal ethics committee of the relevant institution and that the
study was conducted in accordance with "Guide for the Care and
Use of Laboratory Animals" (http://www.nap.edu/catalog/5140.html). Authors must send the approval of the relevant ethics
committee with the article.
If any previously published quoted passages, tables, figures, etc. are
used in the article, authors should obtain written permission from
the publication rights holders and the authors, and should specify
this in the article.
All new submissions are screened for plagiarism by similarity check software (Ithenticate).
Conflicts of Interest:
A conflict of interest is defined as any financial, personal,
academically competitive or intellectual relationship between
the author, referee or editor that involves article submission,
referee evaluation, editorial decision and author-referee-editor
correspondence and that could lead to a prejudiced and unfair
action during the evaluation stage.
The authors must declare any financial relationship or conflict of
interest areas that need to be known regarding the study. All financial
contributions and sponsorships for the study and all financial
relationships and conflict of interest areas should be included in the
copyright transfer form that accompanies the article. The authors
must explain the study sponsor's role in collecting, evaluating
and analyzing the data, writing the article and submitting it for
publication. If there is no conflict of interest, this section must
include a "The authors declare no conflict of interest" statement. All
sources of funding should be mentioned in the manuscript.
The evaluation process for the article is not started if a conflict of
interest statement signed by corresponding author is not present at
the time the article is sent. If a conflict of interest becomes apparent
after the article is published, the journal may make an official
correction or withdraw the entire article.
The referees also need to declare all their interests that they feel may
represent a potential conflict of interest. The referees must declare
to the editor any conflicts of interest that may prejudice their
evaluation of the article and must avoid such evaluation of certain
articles if a potential prejudice is present.
The editors who will make the final decision on the articles cannot
have any personal, professional or financial relationship with any of
the authors of the articles they will decide on. The editors will also
try to avoid any referees who have a possible conflict of interest, for
example those working in the same department or facility as any of
The editors and publisher assume no responsibility regarding
features and explanations of any commercial products advertised in
Turkish Journal of Pathology requires all authors to acknowledge, on the title page of their manuscript, all funding sources that supported their work, as well as all institutional or corporate affiliations of the authors that might pose a conflict of interest in connection with the submitted manuscript.
The confidentiality and privacy of patients and study participants:
Authors should avoid descriptive information such as patient names,
initials, reference numbers or photographs in their article. Such
information can be published if absolutely necessary for scientific
reasons and only after obtaining written "informed consent" from
the patient (or parents, or guardian). The article must also state that
"informed consent" was obtained.
8.RELATIONS WITH EDITOR(S), AUTHOR(S) AND REFEREE(S)
Editors do not share information regarding articles (article receipt,
review process, referee opinions or final results) with anyone except
authors and referees. Referees and editorial board members cannot
discuss articles in a public manner. Editors must send copies of the
article to the editor once their review is complete. Referee reviews
cannot be printed or disclosed without permission of the author
and editor. Care is taken to keep the identities of the referees. In
some cases, the editor may decide to send referee opinions on the
article to other referees reviewing the same article to inform them
during the process. All articles submitted will be subjected to peer
review by the editorial board, and the authors will be informed
within four weeks. Editorial board reserves the right to make some
revisions in the article. Revised articles should also be accompanied
by a unique letter with responses to reviewers' comments. Articles
that do not comply with the journal requirements listed below may
be returned without review at the discretion of the editors. If the
journal requests a revision, the author(s) should submit the revised
version within six months. Otherwise , it will be considered a new
9.PREPARATION OF ARTICLE
Articles should be typed in 12 pt (Times New Roman), double
spaced throughout with margins of 2.5 cm, and pages must be
numbered on the right upper corner. Manuscripts must be in
accordance with the International Committee of Medical Journal
Editors: Uniform Requirements for Manuscripts Submitted to
Biomedical Journals (http://www.icmje.org/). Original articles
should not exceed 15 double spaced typewritten pages, and case
reports should not exceed 10 pages. Articles should be sent in either
"doc" or "txt" format and organized as follows:
a. Title page: The title page should contain the article title,
authors' names, academic titles and affiliations, a running title
not exceeding 40 characters and the address for manuscript
correspondence including e-mail address and telephone and fax
numbers. If the article was presented at a scientific meeting, a
complete statement including the date and place of the meeting
should be provided. An "acknowledgement(s)" section should be placed on the title page to thank those who helped the study or preparation of the article, if any. All funding sources that supported the work and the institutional and/or corporate affiliations of the authors should be acknowledged on the title page. This section contains statements of gratitude for personal, technical or material help, etc.
b. Abstract and keywords: All articles should contain an abstract.
Abstracts must be no longer than 250 words. The abstracts
should be structured [objective, materials and methods,
results and conclusions]. Case reports should also include a
structured abstract [objective, case report(s), and conclusion].
Abbreviations should not be used in the abstract.
The authors should list three to five key words or phrases taken
from Index Medicus Medical Subject Headings (http://www.nlm.nih.gov/mesh/MBrowser.html).
c. Text: Original articles should be organized in four main
headings: introduction, material and method, results, and
discussion. Define abbreviations at first mention in the text
and in each table and figure. If a brand name is cited, supply
the manufacturer's name and address (city and state/country).Case reports should include the following identifiable
sections: introduction, case report(s), and discussion.
d. References: References should be arranged according to
the "Uniform Requirements for Manuscripts Submitted
to Biomedical Journals" rules developed by "International
Committee of Medical Journal Editors (ICMJE)". Some examples
have been provided for frequently used reference types. The
should be used for guidance on other types of references not
provided here. Each reference should be numbered and listed
according to their order in the text. They should be referred
to in parentheses at the end of sentences within the text. The
author(s) are responsible for the accuracy of the references.
Journal titles should be abbreviated according to Index Medicus.
Refer to the "List of Journals Indexed in Index Medicus" for
abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Abbreviations are not used for
journals not in the Index Medicus. Only published articles or
articles "in press" can be used in references. All authors names
must be written, do not use "et al". Authors must add the DOI
and/or PMID numbers to the end of each citation.
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation
in HIV-infected patients. N Engl J Med. 2002;347:284-7. PMID:
12140307 DOI: 10.1056/NEJMsb020632
Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd
ed. Wieczorek RR, editor. White Plains (NY): March of Dimes
Education Services; 2001.
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations
in human solid tumors. In: Vogelstein B, Kinzler KW, editors.
The genetic basis of human cancer. New York: McGraw-Hill;
Christensen S, Oppacher F. An analysis of Koza's computational
effort statistic for genetic programming. In: Foster JA, Lutton E,
Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming.
EuroGP 2002: Proceedings of the 5th European Conference on
Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin:
Springer; 2002. p. 182-91.
e. Tables: Each table must be typed double-spaced on a separate
page following the references. Tables should be numbered
consecutively with Roman numerals in order of appearance
in the text and should include a short descriptive title typed
directly above and essential footnotes including definitions
of abbreviations below. They should be self-explanatory and
should supplement rather than duplicate the material in the
f. Figures: All figures should be numbered sequentially in the text
with Arabic numbers and should be referred to in parentheses
within the text. Art should be created / scanned and saved as
either TIFF or JPEG format, submitted as a separate file, and not
embedded in the text file. Electronic photographs, radiographs,
CT scans, and scanned images must have a resolution of at least
300 dpi and 1200x960 pixels. Writing any text on the figures
should be avoided as much as possible.
g. Figure legends: Include legends for all figures. Legends should
appear on a separate page after the tables, should be brief and
specific, and should include magnification and the stain used.
Abbreviations and symbols used in the figures must be denoted
in the legend.
10.SUBMISSION OF ARTICLES
All manuscripts must be submitted on-line through the web
site (http://www.turkjpath.org/submit/). The corresponding
author should upload the "Turkish Journal of Pathology Author
Responsibility and Copyright Transfer Form" with the main
manuscript. The copyright transfer form can be downloaded from
Authors will receive a complimentary electronic (PDF) reprint of
the article. No hardcopy complimentary reprints are provided by
Copyright Copyright of an accepted article should be transferred to
the Federation of Turkish Pathology Societies. This transfer covers
the exclusive rights to reproduce and distribute the article.
Authors may make this published article available free on-line
provided that the source of the published article is cited and the
Federation of Turkish Pathology Societies is mentioned as copyright
holder. In such a case, a link to the original article in Turkish Journal
of Pathology accompanied by the following statement should also
be created: "The original article is available at http://www.turkjpath.org". All articles published in this journal are protected by copyright.
Manuscripts, figures and tables published in the Turkish Journal of Pathology can be reproduced, archived in a retrieval system,
by providing proper citations. If there are advertising purposes for using Federation's intellectual properties please contact the Federation of
Turkish Pathology Societies. The Federation of Turkish Pathology
Societies does not accept any legal responsibility for errors,
omissions or claims with respect to information published in the
Journal. The "Turkish Journal of Pathology Author Responsibility
and Copyright Transfer Form" must be filled out and uploaded by
the corresponding author with the main manuscript. If the form is
not completed as instructed by the primary author, the manuscript
will not be considered for peer review. Each author should have
participated sufficiently in the work, and the corresponding author
should state this. Each field may include more than one author. The
corresponding author accepts that all information included in the
manuscript is complete and has been agreed on by all authors. Any
conflict of interest obtained by financial or personal relationship
and/or financial and material support should be reported by the
13. OPEN ACCESS POLICY
Turkish Journal of Pathology adopts open access policy. Open access to information benefits the humanity as it improves the global value of information. Turkish Journal of Pathology also supports the Budapest Open Access Initiative that was signed on September 12, 2012. Thus, the open access policies adopted by the editorial board of Turkish Journal of Pathology can be found at http://www.budapestopenaccessinitiative.org/boai-10-recommendations.
All articles published in Turkish Journal of Pathology are licensed with "Creative Commons Attribution 4.0 International License". This license entitles all parties to copy, share and redistribute all the articles, data sets, figures and supplementary files published in this journal in data mining, search engines, web sites, blogs and other digital platforms under the condition of providing references. Open access is an approach that eases the interdisciplinary communication and encourages cooperation among different disciplines. Turkish Journal of Pathology, therefore, contributes to its own field by providing more access to its articles and a more transparent review process.
14. EDITORIAL CORRESPONDENCE
Dr. Ümit Çobanoglu (Editor-in-Chief)
Karadeniz Teknik Üniversitesi, Tip Fakültesi,
Tibbi Patoloji Anabilim Dali, 61080 Trabzon, Turkey
Tel: +90 (462) 377 54 09; +90 (532) 375 38 60
15. PUBLISHER CORRESPONDENCE
Bulus Design and Printing
Bahriye Üçok Caddesi No: 9/1, Besevler,
06500, Ankara, Turkey
Tel : +90 (312) 223 55 44; +90 (312) 222 44 06
Fax: +90 (312) 222 44 07